Introduction. The most common causes of cervical lymphadenopathy (LAP) are inflammatory and reactive conditions; only a small proportion have serious pathology, such as malignancy. The objective of this study was to evaluate the relationship between USG findings and histopathological diagnosis of the cervical LAP. Population and Methods. This retrospective study comprised the cases of cervical LAP in patients aged under 20 years old followed in our center between January 2007 to December 2016. Based on pathology reports, we divided the patients into two groups: benign and malignant. Pathology results and USG findings were compared.
INTRODUCTION
Many different conditions may cause cervical lymphadenopathy (LAP), such as viral or bacterial i n f e c t i o n s , t u b e r c u l o s i s , toxoplasmosis, cat-scratch disease, Kikuchi's disease, collagen vascular disease and neoplasia. 1 However, the most common causes of LAP are inflammatory and reactive conditions, only a small proportion has serious pathology, such as malignancy. 2 Against this small proportion, many parents may be excessively worried about to enlarged lymph node, because of this association.
Fine needle aspiration (FNA) has a substantial role in the diagnosis of cervical lymphadenopathies. 3 However, this diagnostic procedure has its limitations. For example, FNA has a high false-negative rate associated with obtaining a proper tissue specimen for histopathology and children always need sedation or general anesthesia. There is also a potential risk of spreading infection especially because of the mycobacterial lymphadenitis. 4 Excision and histopathological evaluation of the LAP is the gold standard method for the diagnosis. 3 However, the physician should choose the right time to prevent unnecessary surgery and treatment delay for improving outcomes.
U l t r a s o n o g r a p h y ( U S G ) i s a primary diagnostic modality in the assessment of cervical LAP because USG is cost-effective, noninvasive, involves no radiation and easily accessible method and it has also a high sensitivity, up to 96.8 % for detecting malignant cervical LAP in patients with cancer. 5 We can evaluate size, shape, site, border, hilus, echogenicity, adjacent softtissue edema, vascular pattern and intranodal necrosis of the cervical lymph nodes. 6 The objective of this study was to evaluate the relationship between USG findings and histopathological diagnosis of the cervical LAP.
MATERIALS AND METHODS
This retrospective study comprised the cases of cervical LAP in patients under 20 years old who were followed at the Department of Pediatric Oncology at the Gülhane Training and Research Hospital from January 2007 to December 2016. Information of the patients was accessed by way of the electronic medical recording system and patients' files. Based on pathology reports, we divided the patients into two groups: Benign and malignant. Furthermore, we compared the pathology results and USG findings.
The children who had an enlarged cervical LAP for more than 4-6 weeks and unresponsive to initial antibiotic treatment were considered ''persistent' and the biopsy was performed in patients with clinical suspicion (e.g., fixed, hard or rubbery nodes) and USG findings (e.g., non-reactive, conglomerate nodes) related to malignancy. The children who were performed biopsy and USG because of persistent cervical LAP were included in the study. The patients with missing data were excluded. Ultrasonograms were obtained with model HDI 5000, 7-to 12 MHz (Philips Medical Systems, Bothell, WA). The following US findings of cervical lymph nodes were analyzed: Size, long axis/short axis ratio, shape (oval, round), border sharpness (sharp, unsharp), hilum (wide, narrow, and absent), echogenicity (homogeneous, heterogeneous), conglomerate (present, absent), necrosis (present, absent) and intranodal vascular pattern (central, peripheral, mixed and absent).
Lymph node size was assessed by measuring the largest and smallest diameters on the ultrasound screen and was calculated long axis/ short axis ratio. LAP was separated into 2 groups according to their L/S ratio: oval (L/S ratio ≥2) and round (L/T ratio <2). A nodal mass that is greater than 6 cm was accepted as bulky lesion. The vascular pattern of cervical LAP was divided into four groups, according to the location of the vascularity: Central, peripheral, mixed (the presence of central and peripheral flow signals) and no flow or absence of vascular signals within the lymph nodes.
The study protocol was approved by the Medical Ethics Committee of Keçiöğren Training and Research Hospital and conducted in accordance with the ethical principles described by the Declaration of Helsinki.
Statistical analysis
The data were evaluated with SPSS (Statistical Package for Social Sciences) 21.0 program for Windows. Continuous variables were measured as mean and standard deviation. The normality of the distribution of continuous variables was confirmed by Kolmogorov-Smirnov test. Independent t and chi square tests were used to evaluate comparisons between the groups. A p-value <0.05 was considered significant.
RESULTS
In this retrospective study, files of a total of 1100 patients younger than 20 years of age with cervical LAP who were referred to Department of Pediatric Oncology between January 2007 and December 2016 were evaluated and we detected 107 cases (63 benign; 44 malignant) who were performed biopsy and USG.
T h e i n c i d e n c e o f m a l i g n a n t L A P w a s significantly higher in the supraclavicular and posterior cervical regions (70.4 % versus 29.6 %), (p < 0.05). Conversely, benign LAP was found more often in the submandibular and jugular regions (68.2 % versus 31.8 %), (p < 0.05). The clinical and imaging characteristics of benign and malignant cervical LAP were listed in Table 1 , 2.
Nodal size
The long axis diameter of malignant group (mean ± SD) was 29.8 ± 12.3 mm (range, 9-55 mm). The long axis diameter of benign group (mean ± SD) was 27.3 ± 11.1 mm (range, 13-55 mm). There was not a significant difference in the maximum diameter between malignant and benign group (p > 0.05). The short axis diameter of malignant group (mean ± SD) was 18.7 ± 8.8 mm (range, 6-36 mm). The short axis diameter of benign group (mean ± SD) was 13.7 ± 7.3 mm (range, 5.2-30 mm). There was a significant difference in the minimum diameter between malignant and benign group (p < 0.05), (Figure 1) .
Nodal shape
In 34 of 63 benign LAP (54.1 %), L/S ratio was 2 or greater and in 29 of 63 benign LAP (45.9 %), L/S ratio was less than 2. In 36 of 44 malignant LAP (81.8 %), L/S ratio was less than 2, whereas only in 8 of 44 malignant LAP (18.2 %), L/S ratio was 2 or greater. The differences in distribution of malignant and benign LAP in two L/S groups were statistically significant (p < 0.05), (Figure 2 
Nodal flow
Color flow signals were detected in 40 of 44 malignant LAP (90.9 %). Seventeen (38.6 %) LAP showed peripheral flow, 15 (34.1 %) LAP showed mixed vascularity, 8 (18.2 %) LAP showed hilar vascularity and 4 (9.1 %) LAP showed no flow. The vascularity was detected in all 63 benign LAP (100 %). Fifty-seven (90.5 %) LAP showed hilar vascularity, 3 (4.8 %) LAP showed peripheral flow and 3 (4.8 %) LAP showed mixed vascularity. In this study, hilar vascularity for benign LAP was highly statistically significant (p < 0.0001). Peripheral flow and mixed vascularity for malignant LAP were statistically significant (p < 0.05). There was also a statistically significant difference between benign and malignant groups for vascular pattern (p < 0.05).
Nodal hilus
In 45 of 63 benign LAP (71.4 %), a wide central hilus was found and 15 (23.8 %) benign LAP had narrow hilus and in 3 (4.8 %) no hilus was detected. In 20 of 44 malignant LAP (45.5 %), hilus was not detected and 16 (36.4 %) malignant LAP had narrow hilus and in 8 (18.2 %) a wide central hilus was detected. The study showed that wide central hilus for benign nodes and absence of hilum for malignant nodes were highly significant parameters (p < 0.0001). There was also a statistically significant difference between benign and malignant groups for LAP hilus (p < 0.05).
Nodal necrosis
Out of 44 malignant LAP, 40 (90.9 %) nodes showed necrosis and 4 (9.1 %) nodes hadn't any necrosis. out of 63 benign LAP, 60 (95.2 %) nodes had no necrosis and only 3 (4.8 %) nodes had necrosis. There was a statistically significant difference between benign and malignant groups for intranodal necrosis (p < 0.05).
Bulky lymph nodes
Out of 44 malignant LAP, we found 32 (72.2 %) bulky nodes (conglomerate) and 12 (27.8 %) nodes had not bulky lesion. Out of 63 benign LAP, 43 (68.3 %) nodes had not bulky lesion and 20 (31.7 %) nodes had bulky lesion. There was a statistically significant difference between benign and malignant groups for bulky lesion (p < 0.05).
Nodal border
In 37 of 63 benign LAP (58.7 %), a sharp border was found and 26 (41.3 %) benign LAP had an unsharp border. In 24 of 44 malignant LAP (54.5 %), an unsharp border was found and 20 (45.5 %) malignant LAP had a sharp border. There was not a statistically significant difference between benign and malignant groups for sharp border (p > 0.05).
Echogenicity of nodes
Of the 63 benign LAP, 51 (81 %) nodes showed homogenous echotexture and 12 (19 %) heterogeneous echotexture. Of the 44 malignant LAP, 32 (72.7 %) showed heterogeneous echotexture and 12 (27.3 %) homogenous echotexture. There was a statistically significant difference between benign and malignant groups for echogenicity of LAP (p < 0.05).
DISCUSSION
The enlarged cervical LAP is a general clinical problem in children. However, we rarely encounter malignancy in this age group. Özkan et al., assessed histopathological LAP result of 71 patients and reported Hodgkin lymphoma was the most common neoplasm (26.7 %) in malignant group. In benign group, the most common lesion was reactive LAP (28.2 %). 7 Likewise, in another study, Mbise RL et al., analyzed excisional lymph node biopsy of 257 children and reported Hodgkin lymphoma was the predominant cause (34.5 %) of malignant group and reactive LAP ratio was found as 20.6 % in benign group 8 . In our study, we observed reactive LAP (76.2 %) most frequently in benign group and, in malignant group, Hodgkin lymphoma was the most common neoplasm (45.5 %). Our findings are in accordance with these results. However, we found higher rates and we thought it was probably because of the case selection. Figure 1 . Mean values of the long and short axis diameter which belongs to benign and malignant groups Figure 2 . Mean values of L/S ratios which belongs to benign and malignant groups (p<0.05)
The laterality of benign and malignant LAP in children is controversial. 9 Sarsu et al., reported that 91.31 % of the pediatric patients with benign lesion showed unilateral LAP whereas 8.68 % of them presented with bilateral 10 . In another study, carried out by Celenk et al., in malignant group, unilateral/bilateral ratio was 57.4 %/42.6 %. 3 In contrast to these results, Gwili et al., showed that 81 % of the children with benign LAP and 92.7 % of malignant LAP showed bilateral involvement. 11 In our study, 69.8 % of the children with benign LAP showed unilateral involvement whereas 30.2 % of them presented with bilateral and in malignant group, unilateral/bilateral ratio was 93.2 %/6.8 %.
We thought that the case selection and study design may be the reason of this discrepancy.
The nodal size is also a suspicious criterion for differentiating benign from malignant LAP today and in the neck, different cutoff points are proposed for size in different studies. [12] [13] [14] We found statistically significant difference between benign and malignant LAP in terms of their minimum diameter. However, there was not any statistically significant difference between benign and malignant LAP in terms of their maximum diameter. Oguz et al., detected a maximum diameter of more than 2 cm as the appropriate limit with which to distinguish malignant LAP from benign LAP. 15 Additionally, Kuna et al., found a minimum diameter of more than 1.2 cm as the appropriate limit for differentiating benign from malignant LAP and according to Vargas-Vallejo et al., the size of LAP bigger than 3 cm was the most appropriate difference between malignant and benign LAP. 16, 17 Some authors advocate that malignant nodes have usually round shape and some benign conditions such as infectious mononucleosis, bacterial lymphadenitis, tuberculosis, Kawasaki d i s e a s e , c a t s c r a t c h d i s e a s e a n d n o r m a l submandibular/parotid lymph nodes could also have round shape. 6, 12, 18 Therefore, the shape of cervical LAP cannot be a single criterion in the diagnosis by USG. According to the study done by Yu et al, in 21 of 44 benign LAP (47.7 %), L/S ratio was ≤ 2, and in 27 of 50 malignant LAP (54.0 %), the ratio was ≤ 2. They found a low specificity and accuracy related to L/S ratio. 19 Whereas, in our study, we observed statistically significant difference between benign and malignant LAP in terms of their nodal shape. These differences may be due to the sample size and diverse characteristics of the study participants.
Benign LAP could have a marked hilar vascularity because of the increased vessel diameter and blood flow. 20 Additionally, malignant LAP could also have a hilar vascularity because of the presence of micrometastases at the early stage of malignancy. 21 In a study done by Dangore et al., 79 % of benign and 5 % of malignant LAP showed hilar vascularity. 22 In our study of 107 LAP, malignant 18.2 % and benign 76 % showed hilar vascularity. The p value for this criterion was less than 0.0001, which showed the association to be very significant.
Malignant LAP may cause peripheral/ mixed vascularity because of the destruction of hilar vascularity by tumour cells. 22 In a study carried out by Sindhoori et al., in malignant group, peripheral/mixed vascularity ratios were 8 %/76 % and in another study done by Na DG et al., were 6 % and 85 % respectively. 20, 23 Our findings are consistent with these results. In our malignant group, peripheral/mixed vascularity ratios were 38.6 % and 34.1 % respectively. The p value for these criteria was also showed the association to be significant. Our study had different ratios from these studies and we thought it was probably because of the case selection and duration of illness.
The invasion of the lymph node with the malignant cells causes early distortion of internal nodal architecture and resulting in narrowing or absence of hilum. 20 The incidence of wide hilum increases with the inflammatory stimulus and age which is probably related to the increased fatty deposition in the lymph node. 12, 24 Vasallo et al., found that 58 % of benign LAP showed a wide central hilus, 35 % showed a narrow hilus and 8 % no hilus, 48 % of malignant LAP showed no hilus, 46 % showed a narrow hilus and 6 % a wide central hilus. 25 In our study majority of benign LAP showed wide hilum where as in majority of malignant LAP showed absent or narrow hilum and it was statistically significant. However, in a study, 64 % of tubercular LAP also showed absent hilus and 21 % showed narrow hilus. 20 Therefore, we believe that wide, narrow or absence of a hilus should not be used as a single criterion for evaluating cervical LAP.
Intranodal necrosis is a pathologic condition. It has been reported in some cases, such as tuberculosis, inflammatory and malignant diseases. 26 Reshma Vj et al., detected that 36 % of both malignant and tubercular LAP showed intranodal necrosis and they did not detect any necrosis in benign group 14 . In our study, 90.9 % of malignant LAP showed intranodal necrosis, which were all malignant on histopathological evaluation. Benign lymph nodes showed 4.8 % intranodal necrosis. The p value showed significant association. B e n i g n l y m p h n o d e s u s u a l l y t e n d t o have unsharp border because of edema or inflammation of the surrounding tissues and malignant lymph nodes usually tend to have sharp border. Because tumour infiltration causes an increase in the difference between LAP and surrounding tissues. 22 However, Ahuja et al., found that 40 % of malignant LAP and 30 % of benign LAP showed unsharp borders. According to their proposal, border sharpness is not useful in differential diagnosis. 6 In our study, 54.5 % of malignant LAP and 41.3 % of benign LAP showed unsharp borders. Our result was compatible with this study.
Malignant LAP could have heterogeneous echogenic structure because of the intranodal cystic degeneration and calcifications. 27 According to the study conducted by Toriyabe et al., 89 % of malignant LAP had heterogeneous echotexture structure and 90 % of benign LAP had homogenous echotexture structure. 28 Our findings were similar with these results and the p value was statistically significant.
A nodal mass, which is greater than 6 cm, is generally defined as bulky lesion. 29 Al Kadah et al., found that 25 % of malignant LAP had bulky lesion and it was is statistically significant. 30 We observed similar result with this study and it was statistically significant.
There are several limitations to this study. First, this study was a retrospectively designed. Second, the results of study were obtained from a single center with a relatively small sample size. Third, we evaluated only cervical region to determine the relationship between US and biopsy findings for the differentiation of benign from malignant LAP.
CONCLUSION
Cervical LAP is a common problem in the childhood and it is mostly caused by infections. However, it is not always easy to exclude malignancy by physical examination. The present study suggests that there is a relationship between US and biopsy findings for the differentiation of benign from malignant LAP, especially in terms of nodal hilus and intranodal vascular pattern. n
